HRID355673

反应详情

EQUATION

反应方程式

HRID 355673 的结构方程式

AUXILIARIES

试剂、催化剂与溶剂

1

PROCEDURE

实验过程

The mixture of 8,11-dichlorodibenz[b,f][1,4]oxazepine (0.32 g, 1.19 mmol), 1-nonylpiperazine (0.38 g, 1.79 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) (0.72 mL, 0.73 g, 4.77 mmol) in acetonitrile (15 mL) was heated at reflux for 6 h. After the mixture was concentrated, water (20 mL) and ethyl acetate (20 mL) were added. The two phases were separated and the aqueous phase was extracted with ethyl acetate (2×20 mL). The combined ethyl acetate solution was dried over magnesium sulfate and filtered. The filtrate was then concentrated in vacuo to dryness and the residue was subjected to column chromatography using ethyl acetate/hexane (1/2) as the eluent. The compound 8-chloro-11-(4-nonyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine was obtained as a white solid (0.15 g, 28%), m.p. 64°-66° C., MS 440 (M+ +1).

WORKUP

后处理

  1. temperaturewas heated
  2. temperatureat reflux for 6 h
  3. concentrationAfter the mixture was concentrated
  4. additionwater (20 mL) and ethyl acetate (20 mL) were added
  5. customThe two phases were separated
  6. extractionthe aqueous phase was extracted with ethyl acetate (2×20 mL)
  7. dry with materialThe combined ethyl acetate solution was dried over magnesium sulfate
  8. filtrationfiltered
  9. concentrationThe filtrate was then concentrated in vacuo to dryness